HIV-Associated Sensory Impairment: Eyes and Ears

HIV can affect sensory organs directly (viral infection, immune-mediated) and indirectly (opportunistic infections, drug toxicity, vascular). Regular screening is essential for early intervention.

Ocular Manifestations

HIV-Associated Retinopathy (Microvasculopathy)

  • Most common (40–60% in untreated); cotton-wool spots, hemorrhages, microaneurysms.
  • Usually asymptomatic; reflects systemic microvascular disease.

CMV Retinitis (AIDS-Defining)

  • Occurs at CD4 <50; painless floaters, flashes, field loss.
  • Sight-threatening; requires urgent intravitreal/systemic valganciclovir, foscarnet, cidofovir.
  • Immune recovery uveitis (IRU) after ART initiation.

Other Ocular OIs

  • HSV/VZV: acute retinal necrosis (ARN), keratitis
  • Toxoplasma: chorioretinitis
  • Syphilis: posterior uveitis, optic neuritis
  • TB: choroidal tubercles
  • Cryptococcal: optic neuritis, papilledema

Neoplastic

  • Kaposi sarcoma: conjunctival/eyelid lesions
  • Primary CNS lymphoma: vitreoretinal involvement

Drug Toxicity

  • Cidofovir: ocular hypotony, uveitis
  • Rifabutin: uveitis
  • Chloroquine/hydroxychloroquine: retinopathy (rare at HIV doses)

Auditory / Vestibular Manifestations

Sensorineural Hearing Loss (SNHL)

  • Prevalence 20–40% in HIV+ adults; multifactorial.
  • Mechanisms: direct viral infection of cochlea/CN VIII, microvascular ischemia, mitochondrial toxicity (NRTIs — ddI, d4T, AZT), OIs (TB meningitis, cryptococcal meningitis), immune-mediated.
  • Often bilateral, high-frequency, progressive.

Vestibular Dysfunction

  • CN VIII involvement → vertigo, imbalance, oscillopsia.
  • Causes: HIV encephalopathy, OIs (toxoplasmosis, lymphoma), drug toxicity (aminoglycosides for MAC/TB).

Otitis Media / Externa

  • Increased frequency/severity with low CD4; Pseudomonas, Aspergillus, TB.

Screening Recommendations

  • Ophthalmology: Baseline dilated fundus exam at diagnosis; annually if CD4 >200; q3–6mo if CD4 <200 or on specific drugs. Urgent if visual symptoms.
  • Audiology: Baseline audiogram; repeat if symptoms, ototoxic drugs, or CD4 decline. Vestibular testing if dizziness.
  • Patient education: Report floaters, vision loss, hearing changes, dizziness immediately.

With ART and immune recovery, many HIV-related sensory complications have declined, but vigilance remains key—especially in late presenters.

HIV & AIDS - Related Articles